CLM3
CLM3, a pyrazolopyrimidine derivative, is a multiple tyrosine kinase inhibitor. CLM3 shows antiproliferative and proapoptotic activity on endothelial and cancer cells, synergistically enhanced by SN38 (HY-13704). These effects are mainly due to its inhibition of phosphorylation of VEGFR-2, EGFR and RET tyrosine kinases and their related signaling pathways.
For research use only. We do not sell to patients.
- CAS No.: 1312024-59-1
- Formula: C21H21N5
- Molecular Weight:343.42
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
VEGFR2 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| 8305C | IC50 |
9.2 μM
Compound: CLM3
|
Antiproliferative activity against human 8305C cells expressing RET after 72 hrs
Antiproliferative activity against human 8305C cells expressing RET after 72 hrs
|
[PMID: 24447248] |
| TT | IC50 |
26.93 μM
Compound: CLM3
|
Antiproliferative activity against human TT cells
Antiproliferative activity against human TT cells
|
[PMID: 24447248] |
CLM3 (0-100 μM, 72 h) significantly decreases phospho-VEGFR-2, phospho-EGFR and phospho-RET levels in activated endothelial and cancer cells[1].
CLM3 (0-100 μM, 72 h) greatly inhibits the expression of the cyclin D1 gene in endothelial and cancer cells, decreasing the cyclin D1 protein intracellular concentration[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1312024-59-1
-
Molecular Weight 343.42
-
Formula C21H21N5
-
SMILES
C[C@@H](NC1=C2C(N(CCC3=CC=CC=C3)N=C2)=NC=N1)C4=CC=CC=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)